The Manufacturers Life Insurance Company Invests $41.05 Million in Revvity Inc. $RVTY

The Manufacturers Life Insurance Company purchased a new stake in shares of Revvity Inc. (NYSE:RVTYFree Report) during the second quarter, HoldingsChannel.com reports. The institutional investor purchased 368,938 shares of the company’s stock, valued at approximately $41,048,000.

Several other institutional investors also recently modified their holdings of RVTY. New Mexico Educational Retirement Board increased its holdings in Revvity by 1.9% in the 4th quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock worth $524,000 after buying an additional 100 shares in the last quarter. Allworth Financial LP boosted its holdings in shares of Revvity by 8.9% during the 4th quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock valued at $123,000 after acquiring an additional 104 shares during the last quarter. EverSource Wealth Advisors LLC boosted its holdings in shares of Revvity by 17.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock valued at $66,000 after acquiring an additional 109 shares during the last quarter. HighTower Advisors LLC grew its stake in shares of Revvity by 2.6% in the fourth quarter. HighTower Advisors LLC now owns 5,141 shares of the company’s stock worth $497,000 after acquiring an additional 129 shares during the period. Finally, Cary Street Partners Financial LLC grew its stake in shares of Revvity by 1.6% in the fourth quarter. Cary Street Partners Financial LLC now owns 8,941 shares of the company’s stock worth $865,000 after acquiring an additional 141 shares during the period. 86.65% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

RVTY has been the topic of a number of research analyst reports. Robert W. Baird set a $117.00 price objective on shares of Revvity in a research report on Wednesday, May 6th. Wall Street Zen downgraded shares of Revvity from a “buy” rating to a “hold” rating in a research report on Sunday, August 16th. Wolfe Research started coverage on shares of Revvity in a research note on Tuesday, June 2nd. They set a “peer perform” rating for the company. Barclays increased their price target on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Finally, Sanford C. Bernstein started coverage on Revvity in a research note on Friday, June 26th. They issued a “market perform” rating and a $115.00 price target on the stock. Three investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $108.36.

Check Out Our Latest Report on RVTY

Revvity Stock Performance

RVTY opened at $126.31 on Thursday. The company has a current ratio of 1.80, a quick ratio of 1.50 and a debt-to-equity ratio of 0.36. The company has a market cap of $14.09 billion, a price-to-earnings ratio of 60.15, a PEG ratio of 2.27 and a beta of 1.07. The company’s 50 day moving average is $112.94 and its 200 day moving average is $100.82. Revvity Inc. has a 12-month low of $81.22 and a 12-month high of $126.90.

Revvity (NYSE:RVTYGet Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The company had revenue of $729.69 million during the quarter, compared to analyst estimates of $702.96 million. During the same period in the previous year, the business posted $1.18 earnings per share. The firm’s quarterly revenue was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, equities research analysts predict that Revvity Inc. will post 5.36 EPS for the current year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. Revvity’s payout ratio is presently 13.33%.

Revvity Profile

(Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

Featured Articles

Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTYFree Report).

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.